Vera Therapeutics VERA
NASDAQ VERA
$35.94 +0.95 (+2.72%)
As of: Sep 4, 2026 · 3:17 PM EDT

Vera Therapeutics (VERA) Non-Current Deferred Tax Liability (2023)

Vera Therapeutics' (VERA) quarterly Non-Current Deferred Tax Liability came in at $719000.0 in Q4 2023.

Analysis

Vera Therapeutics (VERA) Non-Current Deferred Tax Liability (2023) Analysis & Trends

Vera Therapeutics (VERA) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $719000.0 in Q4 2023.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $719000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $719000.0 (changed N/A YoY) and the FY2023 annual result came in at $719000.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability held at $719000.0 in Q4 2023.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $719000.0 in Q4 2023 to a low of $719000.0 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Vera Therapeutics 2.58 Bn 2.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 719,000.00